These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24951336)

  • 41. Comparison of point-of-care analysis using Coaguchek XS and standard laboratory-measured prothrombin time in dogs.
    Newbould AR; Norman EJ
    N Z Vet J; 2013 Jan; 61(1):18-24. PubMed ID: 22984842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accuracy of coagulation values obtained from a heparinized central venous catheter.
    Pinto KM
    Oncol Nurs Forum; 1994 Apr; 21(3):573-5. PubMed ID: 8052553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT).
    Peterson P; Gottfried EL
    Thromb Haemost; 1982 Apr; 47(2):101-3. PubMed ID: 7101228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin.
    Andrew M; Schmidt B; Mitchell L; Paes B; Ofosu F
    Thromb Haemost; 1990 Feb; 63(1):27-30. PubMed ID: 2339359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
    Hirai N; Tatsumi N; Hino M; Yamane T; Ohta K
    Osaka City Med J; 1998 Jun; 44(1):55-71. PubMed ID: 9834619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluating the analytical performance of five new coagulation assays for the measurement of prothrombin time and activated thromboplastin time.
    Kitchen S; Geisen U; Kappelmayer J; Quehenberger P; Drieß J; Lowe A; Jones R; Boehm JG; Miles G; Rozsnyai G
    Int J Lab Hematol; 2018 Dec; 40(6):645-654. PubMed ID: 30033570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prothrombin time and activated partial thromboplastin time using a point-of-care analyser (Abaxis VSpro®) in Bennett's wallabies (Macropus rufogriseus).
    Nevitt BN; Chinnadurai SK; Watson MK; Langan JN; Adkesson MJ
    Aust Vet J; 2016 Oct; 94(10):384-6. PubMed ID: 27671083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reliability of the portable coagulometer qLabs to accurately measure the activated thromboplastin time and international normalized ratio: a prospective study in critically ill patients.
    Casado-Méndez M; Arellano-Orden V; Muñoz-Gómez M; Rodríguez-Martorell FJ; Cayuela A; Pastor de Las Heras Á; Díaz Martín A; Pérez Torres I; Leal-Noval SR
    Blood Coagul Fibrinolysis; 2018 Nov; 29(7):644-650. PubMed ID: 30234544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of telavancin on coagulation test results.
    Barriere SL; Goldberg MR; Janc JW; Higgins DL; Macy PA; Adcock DM
    Int J Clin Pract; 2011 Jul; 65(7):784-9. PubMed ID: 21564449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measurement of activated coagulation time in children: evaluation of the blood-saving kaolin i-STAT activated coagulation time technique in pediatric cardiac anesthesia.
    Ulmer FF; Baulig W; Béttex D; Spielmann N; Bürki C; Weiss M
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):395-401. PubMed ID: 21376632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring of haemostasis in liver transplantation: comparison of laboratory based and point of care tests.
    Herbstreit F; Winter EM; Peters J; Hartmann M
    Anaesthesia; 2010 Jan; 65(1):44-9. PubMed ID: 19889111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of activated partial thromboplastin time (aPTT) reagents for application in biomedical diagnostic device development.
    Dudek MM; Harris LF; Killard AJ
    Int J Lab Hematol; 2011 Jun; 33(3):272-80. PubMed ID: 21118388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Verifying reference intervals for coagulation tests by using stored data.
    Aral H; Usta M; Cilingirturk AM; Inal BB; Bilgi PT; Guvenen G
    Scand J Clin Lab Invest; 2011 Dec; 71(8):647-52. PubMed ID: 22017165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coagulopathy screening in children with heparinized central venous catheters.
    Ellis MR
    Pediatrics; 1993 Jun; 91(6):1147-50. PubMed ID: 8502518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
    Douxfils J; Mullier F; Robert S; Chatelain C; Chatelain B; Dogné JM
    Thromb Haemost; 2012 May; 107(5):985-97. PubMed ID: 22438031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Performance Evaluation of the Sysmex CS-5100 Automated Coagulation Analyzer.
    Chen L; Chen Y
    Clin Lab; 2015; 61(7):653-60. PubMed ID: 26299062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the Analytical Properties of the Diagon CoagXL Coagulation Analyzer.
    Koç H; Yildiz Z; Hürmeydan Ö; Madenci ÖÇ; Yücel N; Orçun A
    Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prothrombin time, activated partial thromboplastin time, plasma fibrinogen determination. Comparison of two automated coagulation systems: Koagulab 40-A and ACL-100].
    Barbe D; Bauduer F; Tanguy A
    Ann Biol Clin (Paris); 1991; 49(10):507-13. PubMed ID: 1807170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laboratory evaluation of the Coasys® Plus C coagulation analyzer.
    de Bie P; Schornagel WJ; van den Dool EJ; Bakker B; van Dam W; Heckman M; Ağar C; Sturk A; Stroobants AK
    Thromb Res; 2013 Apr; 131(4):357-62. PubMed ID: 23473640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.